Brief: Cellect Biotechnology Commences Collaboration With XNK Therapeutics To Advance Novel Nk Cell-Based Therapies

Quoin Pharmaceuticals

29/10/2020 12:37

Oct 29 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY LTD - COMMENCES COLLABORATION WITH
XNK
THERAPEUTICS TO ADVANCE NOVEL NK CELL-BASED THERAPIES
    * CELLECT BIOTECHNOLOGY - WILL HELP IMPROVE XNK
THERAPEUTICS'
TECHNOLOGY PLATFORM, FOR TARGETING CANCER ACROSS A WIDE RANGE OF
INDICATIONS
    * CELLECT BIOTECHNOLOGY LTD - EXPECTS TO EXPAND BUSINESS
ARRANGEMENT BASED ON OUTCOMES OF ONGOING STUDIES AT XNK
THERAPEUTICS

Source text for Eikon:  ID:nGNX4g9z54 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))